The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including ServiceNow, Inc. (NOW), Alibaba Group ...

Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Avior Wealth Management LLC boosted its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 10.4% during the 4th quarter, according to the company in its most recent filing with the ...

Elevance Health (NYSE:ELV – Free Report) had its price target upped by Barclays from $501.00 to $512.00 in a report published on Friday,Benzinga reports. The firm currently has an overweight rating on ...

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.53%, which ...

Elevance Health Inc (ELV) stock saw a decline, ending the day at $400.96 which represents a decrease of $-0.40 or -0.10% from the prior close of $401.36. The stock opened at $397.16 and touched a low ...

Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Stocks started the week lower, pulled downward by investors' worries about the health of the AI trade. Under the hood of the S&P 500, though, there was still green to be seen.